These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Relation between mesenchymal mucopolysac-charides and blood mucopolysaccharides in peripheral obliterating arteriopathy]. RADINO G Arch Sci Med (Torino); 1960 Feb; 109():180-202. PubMed ID: 14435715 [No Abstract] [Full Text] [Related]
3. [The electrophoretic glycoprotein pattern in chronic obliterating arteriopathy of the lower extremities]. MONTROSI W; GHIRINGHELLI C; BOSELLI G; GALLO G Minerva Cardioangiol; 1957 Oct; 5(10):456-61. PubMed ID: 13503740 [No Abstract] [Full Text] [Related]
4. [Notes on the behavior of the blood coagulation process in chronic obliterating arteriopathy of the extremities]. MANDELLI F; VISCONTI W; CONTORNI L G Clin Med; 1958 May; 39(5):786-802. PubMed ID: 13574546 [No Abstract] [Full Text] [Related]
5. [Electrophoretic studies of lipoprotein and glycoprotein fractions in arterial and venous blood of patients of peripheral obliterating arteriopathy]. RAPISARDA LM; SOMMARIVA V Riv Patol Clin; 1958 Feb; 13(2):63-90. PubMed ID: 13543271 [No Abstract] [Full Text] [Related]
6. [Contribution to the study of thrombophilia in chronic obliterating arteriopathy of the extremities]. VERGANI G; SIDERI GC Osp Maggiore; 1961 May; 49():209-18. PubMed ID: 13780845 [No Abstract] [Full Text] [Related]
7. [The process of blood coagulation in juvenile chronic peripheral obliterating arteriopathies]. SERRANO S; DI GIOVANNI V Minerva Cardioangiol; 1961 Jan; 9():7-13. PubMed ID: 13750305 [No Abstract] [Full Text] [Related]
9. [Bogomoletz serum in therapy of chronic peripheral obliterating arteriopathy]. VERGANI G Gazz Med Ital; 1958 Jan; 117(1):4-5. PubMed ID: 13524597 [No Abstract] [Full Text] [Related]
10. [Research on peripheral hematological changes in action in patients with chronic obliterating arterial diseases]. CASAGRANDE A Minerva Chir; 1959 Feb; 14(4):239-42. PubMed ID: 13656576 [No Abstract] [Full Text] [Related]
11. [Regional changes of blood coagulation in chronic obliterating peripheral arteriopathy]. BASSI M; CERRA R G Ital Chir; 1955 Apr; 11(4):380-91. PubMed ID: 14391704 [No Abstract] [Full Text] [Related]
12. [Variations in the total mucopolysaccharides and mucoproteins in the serum during degenerative vascular disorders; influence of the liver and the adrenal cortex]. BASTENIE PA; CONARD V; OOMS H; SUCZS-VERBIEST M Acta Med Scand; 1958 Mar; 160(3):205-13. PubMed ID: 13532499 [No Abstract] [Full Text] [Related]
13. [Value of erythrosedimentation rate in chronic peripheral obliterating arterial diseases]. CONTI A Riforma Med; 1956 Mar; 70(13):360-3. PubMed ID: 13323966 [No Abstract] [Full Text] [Related]
14. [Various aspects and significance of the blood protein pattern in obstructive peripheral arteriopathy]. DELLA CORTE M Riforma Med; 1958 Nov; 72(48):1361-8. PubMed ID: 13624524 [No Abstract] [Full Text] [Related]
15. [Lacticemic curve after muscular work in peripheral arteriopathy]. MAIRANO C; GIUDICE PA Minerva Chir; 1954 Dec; 9(24):1143-6. PubMed ID: 14355733 [No Abstract] [Full Text] [Related]
16. [Remote results of direct surgery in 18 cases of chronic peripheral obliterating arteriopathy]. BESA G Acta Chir Ital; 1958; 14(2):281-8. PubMed ID: 13532300 [No Abstract] [Full Text] [Related]
19. [Pathogenesis of chronic peripheral obliterating arteriopathy. II. Experimental study of the effect of papaverine on the circulation of the extremities]. BATTEZZATI M; TAGLIAFERRO A Minerva Chir; 1954 Nov; 9(22):1072-4. PubMed ID: 14355718 [No Abstract] [Full Text] [Related]